XI’AN, China, March 23, 2011 /PRNewswire-Asia-FirstCall/ —
Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board:
HFGB) (“Huifeng” or “the Company”), specializing in developing
and producing botanical extracts and other raw materials for
pharmaceuticals and food additives, today announced the appointment
of Ms. Amy Xue to Senior Vice President of Finance.
“We are truly delighted that Ms. Xue will be a part of the
Company,” said Jing’an Wang, Founder, Chairman, and Chief Executive
Officer of Huifeng. “Her appointment is an important step in
strengthening the Company’s internal controls over financial
reporting. Ms. Xue brings a tremendous amount of knowledge and
strategic counsel to our senior management team and we are fully
confident that she will play an integral role in the achievement of
Huifeng’s growth and financial goals.”
Ms. Xue has extensive experience in U.S. GAAP financial
reporting and public accounting, and she has performed audit and
accounting services for companies in a variety of industries. In
2010, she founded Farolfi & Company, LLC, a New York based
accounting and business advisory firm. Prior to that, Ms. Xue was a
senior manager of Acquavella, Chiarelli, Shuster, Berkower &
Co., LLP, a public accounting firm in New York that focuses on SEC
audits with Chinese companies.
Ms. Xue holds a Master’s in accounting from Binghamton
University and a B.S. in law from Peking University in Beijing,
China. She is a U.S. Certified Public Accountant in New York and a
member of the American Institute of Certified Public Accountants
(AICPA).
About Huifeng Bio-Pharmaceutical Technology, Inc.Huifeng
Bio-Pharmaceutical Technology, Inc., located
in Xi’an, People’s Republic of China, develops and
produces plant extracts and pharmaceutical raw materials for use in
pharmaceutical, nutraceutical and food production. It is th
‘/>”/>
